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A BST R AC T   
 
Aim: To evaluate the prevalence of Helicobacter pylori (H. pylori) and related histopathological lesions in 
gastric mucosa samples in this single-center study. 
Methods: Esophagogastroduodenoscopy and endoscopic biopsy reports of 1605 elective cases were 
retrospectively evaluated. Histopathological examination was evaluated according to the Sydney classification. 
The data were analyzed according to the prevalence of H. pylori, age, gender, gastric atrophy and intestinal 
metaplasia rates, and the distribution of the study group in the population below 40 years old and over 40 years 
old. 
Results: 584 males (Mean age 51.5 ± 16.5 years) and 1021 females (mean age 49.6 ± 16 years), (p = 0.03), a 
total of 1605 cases were included in the study. The rate of atrophy, metaplasia and H. pylori positivity in total 
study population were 0.2%, 16%, 71%, respectively. The rate of atrophy in men and women were 1.2% and 
0.8%, respectively (p = 0.006). The rate of metaplasia in men and women were 20.9% and 13.7%, respectively 
(p <0.001). In the population under 40 years of age, the rates of gastric atrophy and intestinal metaplasia were 
0.7% and 2.5%, respectively (p = 0.02), above the age of 40, these rates were determined as 10.8% and 18.4%, 
respectively. (p <0.001).  
Conclusion: According to the data of our center, the prevalence of H. pylori is high. In addition, the rate of 
intestinal metaplasia is relatively high in the male population over the age of 40. 
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Introduction 
Helicobacter pylori (H. pylori) is a common 
infection that infects nearly half of the world's 
population [1]. After ingestion orally, H. pylori 
is colonized in the gastric mucosa by creating a 
micro-alkaline environment thanks to its urease 
enzyme. It causes damage to the gastric 
epithelium with the endotoxins it secretes [2]. If 
it is not eradicated, it may cause many different 
pictures in a wide spectrum ranging from 
chronic gastritis to mucosa-related lymphoma 
and gastric cancer [3].  
World health organization acknowledged it as 
the first-degree agent responsible for 
malignancy and the detection of a reduction in 
the risk of gastric cancer with its eradication 
keep the subject up-to-date [4-6]. While the 
prevalence of H. pylori decreases in parallel 
with the development level of the society and 
good sanitation conditions, it has been reported 
that low socio-economic status, dense family 
population and poor hygiene conditions are 
responsible for the increase in its prevalence 
[7].  
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There are different data from different 
geographical regions of our country about the 
prevalence of H. pylori [8]. The aim of this 
study was to evaluate the prevalence of 
Helicobacter pylori, atrophic gastritis and 
intestinal metaplasia in biopsy samples of 1605 
patients who underwent 
esophagogastroduodenoscopy (EGD) in a 
referral hospital, and to investigate its 
relationship with gender and age. 
 
Materials and methods 
Approval of the study was obtained from 
Pamukkale University clinical research ethics 
committee (24.03.2021-2021 / E.35738). Data 
of 1605 adult cases who applied to Denizli State 
Hospital Gastroenterology Outpatient Clinic 
and underwent elective EGD with different 
indications between October 2015 and May 
2016 were retrospectively evaluated. Pentax 
EPK i-5000 system and EG-2990i model 
gastroscope were used in EGD procedures. 
Patients who had gastrointestinal bleeding in 
the last month, who used antibiotics and 
bismuth salts, who used proton pump inhibitors 
in the last two weeks, and those who could not 
give a clear anamnesis about drug use and 
whose medical records could not be reached 
were excluded [9]. In addition, patients who 
underwent gastric surgery, inpatients, and 
emergency procedures were excluded. 
Endoscopic biopsy specimens taken from the 
two curvatures of the corpus and antrum were 
transported to pathology in formaldehyde 
containing tubes, stained with giemsa and 
toluidine blue, and histopathological 
examination was evaluated according to the 
Sydney classification[10]. The prevalence of H. 
pylori in the EGD treated population, its 
distribution by age and gender, rates of gastric 
atrophy and intestinal metaplasia, as well as the 
distribution of the study group in the group 
under 40 years of age and in the population over 
40 years of age were analyzed. 
SPSS (Statistical Package for Social Sciences) 
for Windows 16.0 program was used for the 
statistical analysis of the findings obtained in 
the study. Values greater than P <0.05 were 
considered significant. The normality of data 
distribution was checked with the Kolmogorov-
Smirnov test. T-test was used for statistics of 
normally distributed data, and Mann-Whitney 
U test was used to compare data that did not 
conform to normal distribution. Categorical 
data were compared using the Chi-square test. 
The Pearson correlation test was used for the 
correlation of the data with normal distribution, 
and the Spearman correlation test was used for 




Total study population was consisted of 1605 
subjects (584 men and 1021 women) enrolled 
to the study. The rate of gastric atrophy, 
intestinal metaplasia and H. pylori positivity in 
total study population were 0.2%, 16%, 71%, 
respectively.  
Mean age of the men was 51.5 ± 16.5 years, 
while mean age of the women was 49.6 ± 16 
years, respectively (p=0.03). The rate of gastric 
atrophy in men and women were 1.2% and 
0.8%, respectively (p=0.006). The rate of 
intestinal metaplasia in men and women were 
20.9% and 13.7%, respectively (p<0.001). The 
rate of H. pylori positivity in men and women 
were 72.1% and 71.5%, respectively (p=0.8). 
We grouped study population according to the 
age either as younger than 40 years (group I) or 
40 years or older (group II). There were 153 
(35.2%) men and 282 (64.8%) women in 
younger than 40 years group while 431 (36.8%) 
men and 739 (63.2%) women in 40 years and 
older group    (p=0.54).     The    rate  of  gastric  
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atrophy in groups I and II were 0.7% and 2.5%, 
respectively (p=0.02). The rate of intestinal 
metaplasia in groups I and II were 10.8% and 
18.4%, respectively (p<0.001). The rate of H. 
pylori positivity in groups I and II were 72.6% 
and 71.4%, respectively (p=0.61). Distribution 
of H. pylori and associated lesions in study 
groups is summarized in Table 1.  
 
Discussion 
The frequency of H. pylori, gastric atrophy and 
intestinal metaplasia in the study population is 
71%, 0.2%, 16%, respectively. While there was 
no significant difference in the prevalence of H. 
pylori in the population aged younger than 40 
and 40 or over, gastric atrophy and intestinal 
metaplasia are significantly higher than the 
younger group 2.5%, 18.4%, respectively. 
Biopsy samples taken from the antrum and 
corpus walls during EGD performed for various 
indications, especially dyspeptic complaints, 
provide valuable information about the gastric 
mucosa and enable us to detect the presence of 
H. pylori [11, 12]. According to the Sydney 
classification, histopathological changes in the 
gastric mucosa guide the clinician about 
potential precancerous lesions [10]. In the 
Kyoto classification, endoscopic findings 
associated with H. pylori gastritis and the 
endoscopic scoring system are recommended to 
be used to predict the risk of gastric cancer [13]. 
The sensitivity and specificity of the 










is high [14]. Patch colonization of H. pylori in 
the gastric lumen is a disadvantage of biopsy. 
Despite the high feasibility of urea breathe test 
in community screenings, its cost poses a 
significant disadvantage. In our study, only one 
method [histopathology) was used to detect H. 
pylori. In a study based on the urea breath test 
conducted throughout Turkey by dividing it 
into five sub-regions, the prevalence of H. 
pylori was found to be 65.7% in the Aegean 
region where our center is located, while this 
rate was relatively high in present study [8]. In 
this study, there was no data that samples were 
taken from our city, and there may be a 
difference depending on the method used in the 
detection of H. pylori. In the reflux study 
conducted by S. Bor et al. [15] from our region, 
the prevalence of H. pylori was 75.7%. In 
another study reported from Afyon province, H. 
pylori prevalence was found to be 73% and 
85% positive in PCR and antral biopsy results 
in dyspeptic patients [16]. Serological 
positivity of H. pylori was reported as 79.7% in 
2001 from the same province [17]. H. pylori 
positivity was found to be 41.4% according to 
the results of CLO test performed on 9239 
patients in Istanbul [18].  H. pylori positivity 
was found to be 57% and it was reported that 
there was no difference between the two 
methods in a study comparing urea breath test 
and histopathology [19]. H. pylori was found to 
be 40% and intestinal metaplasia was found to 
be 18.1% as reported in a  study conducted in 
Table 1. Distribution of H. pylori and associated lesions in study groups. 
Parameters Female Male Total <40 years >40 years P  
H. pylori (+)  730 (71.5%) 421 (72.1%) 1151 (71.7%) 316 (72.6%) 835 (71.4%) NS 
H. pylori (-)  291 (27.9%) 163 (28.5%) 454 (28.3%) 119 (27.4%) 335 (28.6%) NS 
Gas. Atr. (+) 13 (1.3%) 19 (3.3%) 32 (2%) 3 (0.7%) 29 (2.5%) 0.01 
Int. Met (+) 140 (13.7%)  122 (20.9%) 262 (16.3%) 47 (10.8%) 215 (18.4%) <0.001 
Gas. Atr: Gastric atrophy, Int. Metap: Intestinal metaplasia, NS: Non-significant. 
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Konya in 2014 [20]. In a series of 885 cases 
covering 0-17 years of age, the prevalence of H. 
pylori was found to be 47.2%  [21]. Our 
findings were similar to the literature. 
Chronic inflammation and destructions in the 
gastric mucosa that last for years result in 
gastric atrophy and metaplasia if H. pylori 
infection initiated in childhood is not 
eradicated, [3, 22]. The contribution of H. 
pylori to non-cardia gastric cancer is reported to 
be 74.7% [23] . The rates of gastric atrophy and 
intestinal metaplasia found in our study in the 
group above 40 years of age were 2.5% and 
18%, respectively which were similar when 
compared to the results of other centers. 
Intestinal metaplasia rate was reported as 
11.5% from Bursa, while gastric atrophy rate 
was 16.3% and intestinal metaplasia rate was 
13.5% in Thrace region [24, 25]. In two 
different studies presented from Istanbul, the 
prevalence of intestinal metaplasia was 
reported as 13.4% and 17.8% [26, 27].  
Intestinal metaplasia occurs as a result of cells 
migrating from the small or large intestines to 
the stomach as substitution of the damaged 
gastric mucosa. Intestinal metaplasia, which is 
an important step on the way to gastric 
dysplasia, was found to be significantly higher 
in the male population above 40 years of age in 
present report. Undoubtedly, many factors 
other than H. pylori contribute to the 
development of gastric adenocarcinoma, such 
as genetic, environmental factors and eating 
habits [28-30]. Therefore, high H. pylori 
positivity does not always mean a high 
prevalence of gastric cancer. 
This cross-sectional study, which was 
retrospective in design, based on a single center 
and a single method, has no claim other than 
leading large-scale research to be conducted 
under ideal conditions. Another limitation of 
the study is that intestinal metaplasia subgroups 
were not reported in histopathological 
examinations.  
Conclusion 
This cross-sectional study, based on data from 
a single-center referral hospital, showed that the 
prevalence of H. pylori is still high and that the 
prevalence of gastric atrophy and intestinal 
metaplasia is similar to data reported in the 
literature. In addition, gastric atrophy and 
intestinal metaplasia were found to be 
significantly higher in the group over 40 years 
of age. Moreover, multi-centered and ideally 
up-to-date studies are needed on this subject. 
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